Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology. | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder	Recruiting	Not stated	2026-01-30		NCT07379268

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Binzhou Medical University	13
Dezhou Hospital Qilu Hospital of Shandong University	14
Jining First People's Hospital	26
Liaocheng People's Hospital	24
Linyi People's Hospital	31
Qianfoshan Hospital	88
Qilu Hospital of Shandong University	249
Qilu Hospital of Shandong University (Qingdao)	19
Shandong Province Third hospital	8
Shandong Provincial Hospital	112
Taian City Central Hospital	12
The Affiliated Hospital of Qingdao University	124
The Second Hospital of Shandong University	42
Weifang People's Hospital	30
Yantai Yuhuangding Hospital	32
Zaozhuang Municipal Hospital	12
Zibo Central Hospital	16

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Qilu Hospital of Shandong University	Jinan	China	68